Impact of malnutrition and protein-enriched oral nutrition on early recovery after fragility fractures in older adults: the NuTra trial
In brief
Protein-enriched diets did not improve early recovery after fractures in older adults
In this single-center trial of 218 adults aged 70 and older with fragility fractures, 46% screened at nutritional risk; a protein-enriched diet did not reduce complications or improve mobility, hospital stay, or discharge destination versus a standard diet. Nutritional risk tracked with frailty and greater need for institutional care, while age-related comorbidity predicted discharge destination, leaving open whether longer-term nutritional support helps.
- Journal
- BMC geriatrics (Q1)
- Published
- 17 October 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Carolina Vogel, Moritz Heyl, Louis Vollmer, Julia Schuhmacher, Johanna Demissie, Dannik Haas, et al.
- PMID
- 42934566
- DOI
- 10.1186/s12877-026-08247-3
Why clinicians should know about it
- Picked for Internal Medicine (paper of the day, 28 October 2026): Randomized nutrition intervention and recovery in older hospitalized patients
- Picked for Orthopedics and Sports Medicine (paper of the day, 28 October 2026): Protein-enriched diet improves functional mobility at discharge
Abstract
BACKGROUND: Malnutrition is highly prevalent in geriatric trauma patients and is associated with impaired recovery, complications, and reduced likelihood of returning home. Nonetheless, the impact of a targeted protein-enriched diet during the acute hospital stay on patient outcome and rehabilitation remains to be investigated. MATERIALS AND METHODS: This single-center randomized controlled study enrolled patients ≥ 70 years with fragility fractures admitted to a Level I trauma center. Nutritional status was assessed using the Nutritional Risk Screening 2002 and Mini Nutritional Assessment. Patients screened positive in ≥ 1 tool were classified as being at nutritional risk and randomized to a protein-enriched diet (Group A) or standard diet (Group B); patients with negative screening served as observational reference group without nutritional risk (Group C). The intervention targeted 1.5-2.0 g/kg/day protein. Primary outcomes were in-hospital medical complications, surgical site infections and functional mobility at discharge. Secondary outcomes included length of stay, discharge destination, and in-hospital mortality. Multinomial logistic regression assessed independent associations with discharge destination. RESULTS: Of the 218 patients (mean age 81.8 ± 6.9 years; 72.0% female), 100 (45.9%) screened positive for being at nutritional risk and were randomized to intervention (A, n = 46) or control (B, n = 54), while 118 (54.1%) patients without nutritional risk served as reference group (C). Patients at nutritional risk showed higher comorbidity burdens, higher ASA classes, and greater frailty than group C. Medical complications occurred in 45.0% of patients, with no significant differences between groups. Serum albumin decreased and CRP increased during hospitalization, without differences among the groups. Patients in reference group C were more often independently mobile and discharged home, whereas all patients at nutritional risk more frequently required institutional care. In multivariable analysis, a higher age-adjusted CCI was independently associated with discharge destination, whereas no independent effect of the nutritional intervention was observed. CONCLUSION: In this geriatric trauma cohort, being at nutritional risk was closely linked to frailty and multimorbidity. A protein-enriched diet during the acute hospital stay did not translate into measurable short-term benefits regarding complications, functional mobility, length of stay or discharge destination. Nutritional risk should therefore be considered within the broader context of overall vulnerability, and nutritional care may need to be embedded in comprehensive longitudinal rehabilitation strategies extending beyond the acute in-hospital phase. TRIAL REGISTRATION: The study was retrospectively registered at ClinicalTrials.gov on 12 May 2026 (NCT07582575).
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.